Get started
Author

Francesco Puleo

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
2018 · Francesco Puleo, Rémy Nicolle, et al. · Gastroenterology · 591
Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: an Italian multi-institutional comparative study
2014 · Marcello Giuseppe Spampinato, Andrea Coratti, et al. · Surgical Endoscopy · 122
Gut Failure in the ICU
2011 · Francesco Puleo, Marianna Arvanitakis, et al. · Seminars in Respiratory and Critical Care Medicine · 110
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
2020 · R. Nicolle, O. Gayet, et al. · Annals of Oncology · 102
PDF
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
2019 · S. Martens, P. Lefesvre, et al. · Annals of Oncology · 82
PDF
Sonic Hedgehog and Gli1 Expression Predict Outcome in Resected Pancreatic Adenocarcinoma
2014 · Raphaël Maréchal, Jean-Baptiste Bachet, et al. · Clinical Cancer Research · 69
New challenges in perioperative management of pancreatic cancer
2015 · Francesco Puleo · World Journal of Gastroenterology · 60
PDF
Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?
2021 · Pieter Demetter, Raphaël Maréchal, et al. · Frontiers in Oncology · 43
PDF
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
2018 · Caroline Vandeputte, Pashalina Kehagias, et al. · Oncotarget · 35
PDF
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
2025 · Alessandro Audisio, Chiara Gallio, et al. · JAMA Oncology · 32
PDF
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status
2019 · Jerome Raffenne, Remy Nicolle, et al. · Cancers · 29
PDF
Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer
2021 · R. Nicolle, O. Gayet, et al. · Translational Oncology · 21
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features
2021 · Jérôme Raffenne, Fernando A. Martin, et al. · Cancers · 21
PDF
DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer
2016 · A Drouillard, F Puleo, et al. · British Journal of Cancer · 21
PDF
Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
2021 · Tatjana Arsenijevic, Remy Nicolle, et al. · Cancers · 20
PDF
Totally laparoscopic liver resections for primary and metastatic cancer in the elderly: safety, feasibility and short-term outcomes
2012 · Marcello Giuseppe Spampinato, Marianna Arvanitakis, et al. · Surgical Endoscopy · 19
A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
2017 · R Dumont, F Puleo, et al. · PubMed · 17
Assessing the Learning Curve for Totally Laparoscopic Major-Complex Liver Resections: A Single Hepatobiliary Surgeon Experience
2014 · Marcello G. Spampinato, Marianna Arvanitakis, et al. · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · 15
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma
2021 · Marc Hilmi, Jérôme Cros, et al. · European Journal of Cancer · 13
PDF
Preoperative gemcitabine-nab-paclitaxel (G-NP) for (borderline) resectable (BLR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC): Feasibility results and early response monitoring by Diffusion-Weighted (DW) MR.
2016 · Jean-Luc Van Laethem, Maria Antonietta Bali, et al. · Journal of Clinical Oncology · 9
Neoadjuvant immunotherapy in microsatellite instability-high (MSI-H) duodenal adenocarcinoma leads to pathological complete response and paves the way for new strategies
2024 · S. Ziane Bouziane, L. Mans, et al. · European Journal of Cancer · 7
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
2024 · R. Saúde-Conde, T. Vandamme, et al. · ESMO Gastrointestinal Oncology · 3
PDF
LBA2 Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC)
2024 · F. Sclafani, G. Bregni, et al. · Annals of Oncology · 3
PDF
In Deciphering the Future of Adjuvant Treatment in Colon Cancer, the Journey Matters More than the Achievements
2016 · Alain Hendlisz, Francesco Puleo, et al. · Current Colorectal Cancer Reports · 3
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
2024 · Irene Assaf, Giacomo Bregni, et al. · Clinical Colorectal Cancer · 2
Works count: 48
Citation count: 1,456
H-index: 17
I10-index: 19
Year
Topic
Type